Aura Biosciences (AURA) Cash & Equivalents (2020 - 2026)
Aura Biosciences (AURA) posted Cash & Equivalents of $84.8 million for Q1 2026, up 42.47% on a QoQ basis from $59.5 million in Q4 2025, and up 121.82% year-over-year from $38.2 million in Q1 2025.
Aura Biosciences (AURA) Cash & Equivalents (2020 - 2026) Analysis & Trends
Aura Biosciences' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $84.8 million for Q1 2026.
- Quarterly Cash & Equivalents rose 121.82% year-over-year to $84.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.8 million (up 121.82% YoY) and the FY2025 annual result came in at $59.5 million, up 87.79% from the prior year.
- Cash & Equivalents was $84.8 million for Q1 2026 at Aura Biosciences, up from $59.5 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $107.4 million in Q2 2025 and bottomed at $20000.0 in Q4 2022.
- A 5-year average of $38.5 million and a median of $38.2 million in 2025 frame the typical range for Cash & Equivalents.
- Peak annual rise in Cash & Equivalents reached 305450.0% in 2022, while the deepest fall reached 99.99% in 2022.
- Aura Biosciences' Cash & Equivalents stood at $20000.0 in 2022, then soared by 205215.0% to $41.1 million in 2023, then slipped by 22.82% to $31.7 million in 2024, then soared by 87.79% to $59.5 million in 2025, then soared by 42.47% to $84.8 million in 2026.
- Business Quant data shows AURA's Cash & Equivalents at $84.8 million in Q1 2026, $59.5 million in Q4 2025, and $47.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | 84.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.79 Mn |
| Dec 31, 2025 | 59.52 Mn |
| Sep 30, 2025 | 47.55 Mn |
| Jun 30, 2025 | 107.37 Mn |
| Mar 31, 2025 | 38.23 Mn |
| Dec 31, 2024 | 31.69 Mn |
| Sep 30, 2024 | 25.41 Mn |
| Jun 30, 2024 | 30.08 Mn |
| Mar 31, 2024 | 26.28 Mn |
| Dec 31, 2023 | 41.06 Mn |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 47.73 Mn |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Sep 30, 2022 | 61.11 Mn |
| Jun 30, 2022 | 53.85 Mn |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 149.06 Mn |
| Sep 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 92.20 Mn |